- Home
- WHLR vs PLRZ Comparison
WHLR vs PLRZ Comparison
Compare WHLR & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- PLRZ
- Stock Information
- Founded
- WHLR 2011
- PLRZ 2005
- Country
- WHLR United States
- PLRZ Israel
- Employees
- WHLR N/A
- PLRZ N/A
- Industry
- WHLR Real Estate Investment Trusts
- PLRZ
- Sector
- WHLR Real Estate
- PLRZ
- Exchange
- WHLR Nasdaq
- PLRZ NYSE
- Market Cap
- WHLR 2.8M
- PLRZ 2.3M
- IPO Year
- WHLR 2012
- PLRZ 2024
- Fundamental
- Price
- WHLR $3.41
- PLRZ $0.39
- Analyst Decision
- WHLR
- PLRZ
- Analyst Count
- WHLR 0
- PLRZ 0
- Target Price
- WHLR N/A
- PLRZ N/A
- AVG Volume (30 Days)
- WHLR 373.7K
- PLRZ 648.7K
- Earning Date
- WHLR 05-05-2025
- PLRZ 02-15-2025
- Dividend Yield
- WHLR N/A
- PLRZ N/A
- EPS Growth
- WHLR N/A
- PLRZ N/A
- EPS
- WHLR N/A
- PLRZ N/A
- Revenue
- WHLR $104,307,000.00
- PLRZ N/A
- Revenue This Year
- WHLR N/A
- PLRZ N/A
- Revenue Next Year
- WHLR N/A
- PLRZ N/A
- P/E Ratio
- WHLR N/A
- PLRZ N/A
- Revenue Growth
- WHLR 2.26
- PLRZ N/A
- 52 Week Low
- WHLR $2.92
- PLRZ $0.28
- 52 Week High
- WHLR $15,552.00
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- WHLR 20.79
- PLRZ N/A
- Support Level
- WHLR $5.20
- PLRZ N/A
- Resistance Level
- WHLR $4.50
- PLRZ N/A
- Average True Range (ATR)
- WHLR 0.74
- PLRZ 0.00
- MACD
- WHLR 0.99
- PLRZ 0.00
- Stochastic Oscillator
- WHLR 11.65
- PLRZ 0.00
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.